James Hippel Power - 15 Aug 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Aug 2026, 17:13:41 UTC
Prior SEC filing
31 Jul 2026
Next SEC filing
19 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed

Key filing fact

James Hippel Power filed Form 4 for BIO-TECHNE Corp (TECH) on 18 Aug 2026.

Key facts

  • This page summarizes James Hippel Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 7 reported transactions and 14 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2026, 17:13.

Change

  • Previous filing in this sequence was filed on 31 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001603594 Primary reporting owner

Hippel James

Relationship
CFO
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
Signature date
18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares
+9,779
Change %
+5.9%
Price
$0.000000*
Shares after
174,493
Date
15 Aug 2026
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
Shares
-4,310
Change %
-2.5%
Price
$72.40*
Shares after
170,183
Date
15 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Performance Restricted Stock Units

Options Exercise

Transaction value
Shares
-866
Change %
-6.2%
Price
$0.000000*
Shares after
12,999
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
866
Exercise price
Footnotes
F2, F3
TECH transaction Derivative

Performance Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-12,999
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,999
Exercise price
Footnotes
F2, F3
TECH transaction Derivative

Performance Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-34,982
Change %
-94%
Price
$0.000000*
Shares after
2,332
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
34,982
Exercise price
$84.61
Footnotes
F4
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,010
Change %
-50%
Price
$0.000000*
Shares after
4,011
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,010
Exercise price
Footnotes
F2, F7
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,903
Change %
-33%
Price
$0.000000*
Shares after
9,807
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,903
Exercise price
Footnotes
F2, F11
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
167,328
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
167,328
Exercise price
$66.97
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
40,536
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,536
Exercise price
$120.46
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
45,220
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,220
Exercise price
$94.52
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
45,923
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,923
Exercise price
$84.61
Footnotes
F5
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,062
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,062
Exercise price
Footnotes
F2, F6
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,417
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,417
Exercise price
$74.91
Footnotes
F8
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,089
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,089
Exercise price
Footnotes
F2, F9
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,420
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,420
Exercise price
Footnotes
F2, F10
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
37,632
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
37,632
Exercise price
$53.60
Footnotes
F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Fully exercisable.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

Footnote F3

On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited.

Footnote F4

On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited.

Footnote F5

Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.

Footnote F6

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F7

4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.

Footnote F8

Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.

Footnote F9

11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.

Footnote F10

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F11

4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.

Footnote F12

Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .